Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,126 | -4,983 | -18,948 | -14,764 | -10,025 |
| Depreciation Amortization | 8 | 4 | 16 | 12 | 7 |
| Accounts receivable | 0 | 0 | 11 | 11 | 12 |
| Accounts payable and accrued liabilities | 555 | 949 | 1,759 | 2,288 | 1,211 |
| Other Working Capital | -4,335 | 222 | -301 | 281 | 376 |
| Other Operating Activity | 117,622 | -616 | -469 | -1,330 | -614 |
| Operating Cash Flow | $-14,276 | $-4,424 | $-17,932 | $-13,502 | $-9,033 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -14 | -14 | N/A |
| Net Acquisitions | -3,648 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3,648 | $N/A | $-14 | $-14 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,999 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $13,999 | $0 | $N/A | $0 | $N/A |
| Exchange Rate Effect | -10 | -7 | 10 | 3 | 5 |
| Beginning Cash Position | 20,821 | 20,821 | 38,757 | 38,757 | 38,757 |
| End Cash Position | 16,886 | 16,390 | 20,821 | 25,244 | 29,729 |
| Net Cash Flow | $-3,935 | $-4,431 | $-17,936 | $-13,513 | $-9,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,276 | -4,424 | -17,932 | -13,502 | -9,033 |
| Capital Expenditure | N/A | N/A | -14 | -14 | N/A |
| Free Cash Flow | -14,276 | -4,424 | -17,946 | -13,516 | -9,033 |